Magnolia Medical Captures $20M to Reduce Blood Culture Contamination

Magnolia Medical Technologies, a Seattle-based manufacturer of devices for collecting blood and bodily fluids, announced this week it has raised $20 million in equity funding to ramp up sales of its flagship product. The funding comes as Magnolia and San Diego-based competitor Kurin battle each other in court. RTW Investments, a New York-based firm that [?]